Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Influenza virus RNA recovered from droplets and droplet nuclei emitted by adults in an acute care setting.

Yip L, Finn M, Granados A, Prost K, McGeer A, Gubbay JB, Scott J, Mubareka S.

J Occup Environ Hyg. 2019 May;16(5):341-348. doi: 10.1080/15459624.2019.1591626. Epub 2019 May 3.

PMID:
31050610
2.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ā€ˇpossible cohort effect following the 2009 influenza pandemic.

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB.

Euro Surveill. 2019 Apr;24(15). doi: 10.2807/1560-7917.ES.2019.24.15.1900104.

3.

Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.

Buchan SA, Chung H, Karnauchow T, McNally JD, Campitelli MA, Gubbay JB, Katz K, McGeer AJ, Richardson DC, Richardson SE, Simor A, Smieja M, Zahariadis G, Tran D, Crowcroft NS, Rosella LC, Kwong JC.

Pediatr Infect Dis J. 2019 Apr;38(4):362-369. doi: 10.1097/INF.0000000000002164.

PMID:
30882725
4.

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Chan T, Bastien N, Li Y, Krajden M, De Serres G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1900055.

5.

Effects of Absolute Humidity, Relative Humidity, Temperature, and Wind Speed on Influenza Activity in Toronto, Ontario, Canada.

Peci A, Winter AL, Li Y, Gnaneshan S, Liu J, Mubareka S, Gubbay JB.

Appl Environ Microbiol. 2019 Mar 6;85(6). pii: e02426-18. doi: 10.1128/AEM.02426-18. Print 2019 Mar 15.

6.

Genetic characterization of human metapneumovirus identified through community and facility-based surveillance of infants in Dhaka, Bangladesh.

Rahman MZ, Sumiya M, Sahabuddin M, Pell LG, Gubbay JB, Rahman R, Momtaz F, Azmuda N, Shanta SS, Jahan I, Rahman M, Mahmud AA, Roth DE, Morris SK.

J Med Virol. 2019 Apr;91(4):549-554. doi: 10.1002/jmv.25351. Epub 2018 Nov 13.

PMID:
30372530
7.

Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, Martineau C, Hickman R, Chan T, Jassem A, Petric M, Rose C, Bastien N, Li Y, Krajden M.

Clin Infect Dis. 2018 Oct 11. doi: 10.1093/cid/ciy876. [Epub ahead of print]

8.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

Chambers C, Skowronski DM, Rose C, Serres G, Winter AL, Dickinson JA, Jassem A, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Petric M, Krajden M.

Open Forum Infect Dis. 2018 Sep 4;5(9):ofy211. doi: 10.1093/ofid/ofy211. eCollection 2018 Sep.

9.

Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Mehta K, Goneau LW, Wong J, L'Huillier AG, Gubbay JB.

Curr Infect Dis Rep. 2018 Aug 1;20(10):38. doi: 10.1007/s11908-018-0643-8. Review.

PMID:
30069787
10.

Zoonotic Influenza and Human Health-Part 1: Virology and Epidemiology of Zoonotic Influenzas.

Goneau LW, Mehta K, Wong J, L'Huillier AG, Gubbay JB.

Curr Infect Dis Rep. 2018 Aug 1;20(10):37. doi: 10.1007/s11908-018-0642-9. Review.

PMID:
30069735
11.

Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.

Golden AR, Adam HJ, Karlowsky JA, Baxter M, Nichol KA, Martin I, Demczuk W, Van Caeseele P, Gubbay JB, Lefebvre B, Levett PN, Zahariadis G, Haldane D, Gad R, German G, Gilmour MW, Mulvey MR, Hoban DJ, Zhanel GG; Canadian Antimicrobial Resistance Alliance (CARA).

J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii20-vii31. doi: 10.1093/jac/dky157.

PMID:
29982573
12.

Limitations of administrative data to identify measles cases in Ontario, Canada: a cautionary tale.

Johnson C, Chen C, Rosella L, Rilkoff H, Marchand-Austin A, Gubbay JB, Kozlowski T, Deeks SL, Mazzulli T, Crowcroft N.

Can J Public Health. 2018 Feb;109(1):3-7. doi: 10.17269/s41997-018-0021-1. Epub 2018 Feb 26.

PMID:
29981059
13.

Laboratory testing and phylogenetic analysis during a mumps outbreak in Ontario, Canada.

L'Huillier AG, Eshaghi A, Racey CS, Ogbulafor K, Lombos E, Higgins RR, Alexander DC, Kristjanson E, Maregmen J, Gubbay JB, Mazzulli T.

Virol J. 2018 Jun 5;15(1):98. doi: 10.1186/s12985-018-0996-5.

14.

Canada-Wide Epidemic of emm74 Group A Streptococcus Invasive Disease.

Teatero S, McGeer A, Tyrrell GJ, Hoang L, Smadi H, Domingo MC, Levett PN, Finkelstein M, Dewar K, Plevneshi A, Athey TBT, Gubbay JB, Mulvey MR, Martin I, Demczuk W, Fittipaldi N.

Open Forum Infect Dis. 2018 Apr 20;5(5):ofy085. doi: 10.1093/ofid/ofy085. eCollection 2018 May.

15.

Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program.

Isabel S, Higgins RR, Peci A, Isabel MR, Deeks SL, Gubbay JB.

Vaccine. 2018 Apr 5;36(15):2033-2040. doi: 10.1016/j.vaccine.2018.02.064. Epub 2018 Mar 8.

PMID:
29526372
16.

Use of Genome Sequencing to Define Institutional Influenza Outbreaks, Toronto, Ontario, Canada, 2014-15.

MacFadden DR, McGeer A, Athey T, Perusini S, Olsha R, Li A, Eshaghi A, Gubbay JB, Hanage WP.

Emerg Infect Dis. 2018 Mar;24(3):492-497. doi: 10.3201/eid2403.171499.

17.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.

Skowronski DM, Chambers C, De Serres G, Dickinson JA, Winter AL, Hickman R, Chan T, Jassem AN, Drews SJ, Charest H, Gubbay JB, Bastien N, Li Y, Krajden M.

Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035. Erratum in: Euro Surveill. 2018 Jul;23(30):.

18.

Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection.

Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis G, Gubbay JB.

N Engl J Med. 2018 Jan 25;378(4):345-353. doi: 10.1056/NEJMoa1702090.

19.

Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.

Buchan SA, Chung H, Campitelli MA, Crowcroft NS, Gubbay JB, Karnauchow T, Katz K, McGeer AJ, McNally JD, Richardson D, Richardson SE, Rosella LC, Simor A, Smieja M, Tran D, Zahariadis G, Kwong JC.

PLoS One. 2017 Nov 17;12(11):e0187834. doi: 10.1371/journal.pone.0187834. eCollection 2017.

20.

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y.

J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.

21.

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y.

J Infect Dis. 2017 Sep 15;216(6):697-702. doi: 10.1093/infdis/jix393.

22.

Lineage-specific epitope profiles for HPAI H5 pre-pandemic vaccine selection and evaluation.

Qiu X, Duvvuri VR, Gubbay JB, Webby RJ, Kayali G, Bahl J.

Influenza Other Respir Viruses. 2017 Sep;11(5):445-456. doi: 10.1111/irv.12466. Epub 2017 Aug 12.

23.

Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.

Thomas S, Hiebert J, Gubbay JB, Gournis E, Sharron J, Severini A, Jiaravuthisan M, Shane A, Jaeger V, Crowcroft NS, Fediurek J, Sander B, Mazzulli T, Schulz H, Deeks SL.

Emerg Infect Dis. 2017 Jul;23(7):1063-1069. doi: 10.3201/eid2307.161145.

24.

Epidemiology of Zika virus, 1947-2007.

Posen HJ, Keystone JS, Gubbay JB, Morris SK.

BMJ Glob Health. 2016 Aug 1;1(2):e000087. doi: 10.1136/bmjgh-2016-000087. eCollection 2016.

25.

Measuring influenza RNA quantity after prolonged storage or multiple freeze/thaw cycles.

Granados A, Petrich A, McGeer A, Gubbay JB.

J Virol Methods. 2017 Sep;247:45-50. doi: 10.1016/j.jviromet.2017.05.018. Epub 2017 May 29.

PMID:
28572040
26.

Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing.

L'Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB.

J Clin Microbiol. 2017 Aug;55(8):2462-2471. doi: 10.1128/JCM.00442-17. Epub 2017 May 31.

27.

Global Distribution and Evolutionary History of Enterovirus D68, with Emphasis on the 2014 Outbreak in Ontario, Canada.

Eshaghi A, Duvvuri VR, Isabel S, Banh P, Li A, Peci A, Patel SN, Gubbay JB.

Front Microbiol. 2017 Mar 1;8:257. doi: 10.3389/fmicb.2017.00257. eCollection 2017.

28.

Evaluation of Altona Diagnostics RealStar Zika Virus Reverse Transcription-PCR Test Kit for Zika Virus PCR Testing.

L'Huillier AG, Lombos E, Tang E, Perusini S, Eshaghi A, Nagra S, Frantz C, Olsha R, Kristjanson E, Dimitrova K, Safronetz D, Drebot M, Gubbay JB.

J Clin Microbiol. 2017 May;55(5):1576-1584. doi: 10.1128/JCM.02153-16. Epub 2017 Mar 15.

29.

Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.

Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M.

Euro Surveill. 2017 Feb 9;22(6). pii: 30460. doi: 10.2807/1560-7917.ES.2017.22.6.30460.

30.

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ.

J Infect Dis. 2017 Apr 1;215(7):1059-1099. doi: 10.1093/infdis/jix074.

31.

Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.

Coleman BL, Hassan K, Green K, Gubbay JB, Katz K, Mazzulli T, McNeil S, Muller M, Powis J, Richardson D, Simor A; TIBDN, McGeer AJ.

Antiviral Res. 2017 Apr;140:158-163. doi: 10.1016/j.antiviral.2017.01.025. Epub 2017 Feb 6.

PMID:
28179155
32.

Whole-genome Sequencing for Surveillance of Invasive Pneumococcal Diseases in Ontario, Canada: Rapid Prediction of Genotype, Antibiotic Resistance and Characterization of Emerging Serotype 22F.

Deng X, Memari N, Teatero S, Athey T, Isabel M, Mazzulli T, Fittipaldi N, Gubbay JB.

Front Microbiol. 2016 Dec 27;7:2099. doi: 10.3389/fmicb.2016.02099. eCollection 2016.

33.

Detecting and quantifying influenza virus with self- versus investigator-collected mid-turbinate nasal swabs.

Granados A, Quach S, McGeer A, Gubbay JB, Kwong JC.

J Med Virol. 2017 Jul;89(7):1295-1299. doi: 10.1002/jmv.24753. Epub 2017 Feb 27.

PMID:
27943313
34.

Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections.

Granados A, Peci A, McGeer A, Gubbay JB.

J Clin Virol. 2017 Jan;86:14-19. doi: 10.1016/j.jcv.2016.11.008. Epub 2016 Nov 22.

PMID:
27893998
35.

Evaluation and Comparison of Multiple Test Methods, Including Real-time PCR, for Legionella Detection in Clinical Specimens.

Peci A, Winter AL, Gubbay JB.

Front Public Health. 2016 Aug 31;4:175. doi: 10.3389/fpubh.2016.00175. eCollection 2016.

36.

Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada.

Kariyawasam R, Lau R, Eshaghi A, Patel SN, Sider D, Gubbay JB, Boggild AK.

Emerg Infect Dis. 2016 May;22(5):854-61. doi: 10.3201/eid2205.151875.

37.

Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada.

Duvvuri VR, Deng X, Teatero S, Memari N, Athey T, Fittipaldi N, Gubbay JB.

Infect Genet Evol. 2016 Aug;42:1-8. doi: 10.1016/j.meegid.2016.04.007. Epub 2016 Apr 9.

PMID:
27071529
38.

A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Krajden M, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Kwindt TL, Bastien N, Li Y.

Clin Infect Dis. 2016 Jul 1;63(1):21-32. doi: 10.1093/cid/ciw176. Epub 2016 Mar 29.

39.

Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.

Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Krajden M, Bastien N, Li Y.

Euro Surveill. 2016;21(11):30168. doi: 10.2807/1560-7917.ES.2016.21.11.30168.

40.

Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses.

Skowronski DM, Sabaiduc S, Chambers C, Eshaghi A, Gubbay JB, Krajden M, Drews SJ, Martineau C, De Serres G, Dickinson JA, Winter AL, Bastien N, Li Y.

Euro Surveill. 2016;21(3):30112. doi: 10.2807/1560-7917.ES.2016.21.3.30112.

41.

Epidemiology of Enterovirus D68 in Ontario.

Peci A, Winter AL, Warshawsky B, Booth TF, Eshaghi A, Li A, Perusini S, Olsha R, Marchand-Austin A, Kristjanson E, Gubbay JB.

PLoS One. 2015 Nov 23;10(11):e0142841. doi: 10.1371/journal.pone.0142841. eCollection 2015.

42.

Influenza virus emitted by naturally-infected hosts in a healthcare setting.

Mubareka S, Granados A, Naik U, Darwish I, Cutts TA, Astrakianakis G, Gubbay JB, Peci A, Scott JA.

J Clin Virol. 2015 Dec;73:105-107. doi: 10.1016/j.jcv.2015.11.002. Epub 2015 Nov 4.

PMID:
26590688
43.

High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada.

Athey TB, Teatero S, Sieswerda LE, Gubbay JB, Marchand-Austin A, Li A, Wasserscheid J, Dewar K, McGeer A, Williams D, Fittipaldi N.

J Clin Microbiol. 2016 Jan;54(1):83-92. doi: 10.1128/JCM.02201-15. Epub 2015 Oct 21.

44.

Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics.

Duvvuri VR, Granados A, Rosenfeld P, Bahl J, Eshaghi A, Gubbay JB.

Sci Rep. 2015 Sep 30;5:14268. doi: 10.1038/srep14268.

45.

Acute Respiratory Infections in Travelers Returning from MERS-CoV-Affected Areas.

German M, Olsha R, Kristjanson E, Marchand-Austin A, Peci A, Winter AL, Gubbay JB.

Emerg Infect Dis. 2015 Sep;21(9):1654-6. doi: 10.3201/eid2109.150472.

46.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Sep 11;33(38):4910-5. doi: 10.1016/j.vaccine.2015.07.044. Epub 2015 Jul 29.

47.
48.

Genetic analysis of invasive pneumococcal isolates from children in Ontario, Canada, 2007-2012.

Deng X, Arya G, Memari N, Mackenzie R, MacMullin G, Low DE, Pillai DR, Gubbay JB.

Pediatr Infect Dis J. 2015 Jun;34(6):594-8. doi: 10.1097/INF.0000000000000697.

PMID:
25831418
49.

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Dickinson JA, Winter AL, Drews SJ, Fonseca K, Charest H, Gubbay JB, Petric M, Krajden M, Kwindt TL, Martineau C, Eshaghi A, Bastien N, Li Y.

Euro Surveill. 2015 Jan 29;20(4). pii: 21022. No abstract available.

50.

Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.

Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group.

Vaccine. 2015 Jan 15;33(4):535-41. doi: 10.1016/j.vaccine.2014.11.044. Epub 2014 Dec 6.

Supplemental Content

Loading ...
Support Center